Clinical trial
Thalidomide and Dacarbazine for Metastatic Melanoma
NCT00006200 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00006200 |
|---|---|
| Title | Thalidomide and Dacarbazine for Metastatic Melanoma |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma |
| Intervention type | Drug |
| Interventions | thalidomide, dacarbazine |
| First posted | Sep 11, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: